Literature DB >> 32255492

Global Hepatitis B Virus Elimination by 2030: China Is Pivotal and Instructive.

Gregory J Dore1, Benjamin Cowie2.   

Abstract

Entities:  

Keywords:  China; elimination; hepatitis B; modeling

Year:  2021        PMID： 32255492     DOI： 10.1093/cid/ciaa138

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  3 in total

1.  Proteomic characterization of the natural history of chronic HBV infection revealed by tandem mass tag-based quantitative proteomics approach.

Authors:  Zhen Xun; Xiaobao Yao; Chenggong Zhu; Yuchen Ye; Songhang Wu; Tianbin Chen; Yongbin Zeng; Caorui Lin; Bin Yang; Qishui Ou; Can Liu
Journal:  Mater Today Bio       Date:  2022-05-25

2.  Exosomal lncRNA HOTTIP Mediates Antiviral Effect of Tenofovir Alafenamide (TAF) on HBV Infection.

Authors:  Qing-Min Liu; Yi-Yu He; Li-Li Liu; Li-Kun Wang
Journal:  J Inflamm Res       Date:  2021-10-23

3.  Epidemiological Characteristics of Infectious Diseases Among Travelers Between China and Foreign Countries Before and During the Early Stage of the COVID-19 Pandemic.

Authors:  Zheng Luo; Wei Wang; Yibo Ding; Jiaxin Xie; Jinhua Lu; Wen Xue; Yichen Chen; Ruiping Wang; Xiaopan Li; Lile Wu
Journal:  Front Public Health       Date:  2021-11-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.